Long COVID and HRQoL v0.1

  • Research type

    Research Study

  • Full title

    Quality-of-life in patients with long COVID: harnessing the scale of big data to quantify the health and economic costs

  • IRAS ID

    304354

  • Contact name

    Rosalind Eggo

  • Contact email

    r.eggo@lshtm.ac.uk

  • Sponsor organisation

    London School of Hygiene and Tropical Medicine

  • Duration of Study in the UK

    0 years, 8 months, 31 days

  • Research summary

    Background: Long COVID is estimated to affect 1.7 million people in the UK. One way of assessing the impact of long COVID is to measure quality-of-life through a standard questionnaire, which can then be used to understand the costs of long COVID to the NHS and wider economy. The impact of long COVID on these measures is not currently known. It is important to understand who is worst affected by long COVID and the cost to the NHS, so that strategies like booster vaccines can be prioritised to the right people.

    Aim: OpenPROMPT aims to understand the impact of long COVID on quality-of-life in adults in English primary care.

    Methods: We will ask people to participate in the study by downloading a smartphone app, and completing a series of questionnaires held within the app. Questionnaires will ask about quality of life, productivity and symptoms of long COVID. Participants will be asked to fill in the questionnaires once a month, for four months. Electronic reminders will be sent to participants to ask them to complete the questionnaires, which will take roughly 15 minutes to complete each month. Participants will also be asked to give consent for linkage of their questionnaire responses to their existing health records.

    The results will tell us if long COVID has different quality-of-life and economic impacts among people of different ages, ethnicities, geographic regions, or because of any underlying health conditions. These results can be converted into standardised measurements used by the NHS to measure the impact of illnesses and the cost of long COVID to health services.

    Impact: Together with other researchers studying long COVID, we will provide results to support long-term care, and make recommendations for prevention of long COVID in the future. At all stages we will ensure that the input of patients and the public is central to running the study and interpreting the outputs.

  • REC name

    South Central - Berkshire B Research Ethics Committee

  • REC reference

    22/SC/0198

  • Date of REC Opinion

    7 Jun 2022

  • REC opinion

    Favourable Opinion